![Andre J. Gudger](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andre J. Gudger
Direktor/Vorstandsmitglied bei
CytoDel LLC
Profil
Andre J.
Gudger is currently the Director at CytoDel LLC.
Previously, he was the Chairman & Chief Executive Officer at Solvern Innovations, Inc. from 2003 to 2009.
He obtained an undergraduate degree from the University of Maryland and an MBA from The University of North Carolina at Charlotte.
Aktive Positionen von Andre J. Gudger
| Unternehmen | Position | Beginn |
|---|---|---|
CytoDel LLC
 CytoDel LLC BiotechnologyHealth Technology Operates as a biopharmaceutical company which produces recombinant derivatives of botulinum neurotoxin | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Andre J. Gudger
| Unternehmen | Position | Ende |
|---|---|---|
Solvern Innovations, Inc.
 Solvern Innovations, Inc. Information Technology ServicesTechnology Services Provides information technology development and consultation services | Vorsitzender | 01.01.2009 |
Ausbildung von Andre J. Gudger
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
9
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
University of Maryland
 University of Maryland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Solvern Innovations, Inc.
Solvern Innovations, Inc. Information Technology ServicesTechnology Services Provides information technology development and consultation services | Technology Services |
The University of North Carolina at Charlotte
 The University of North Carolina at Charlotte Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CytoDel LLC
CytoDel LLC BiotechnologyHealth Technology Operates as a biopharmaceutical company which produces recombinant derivatives of botulinum neurotoxin | Health Technology |
